BioLife Solutions, Inc. Available-for-sale Securities, Amortized Cost Basis
BioLife Solutions, Inc. (BLFS) had Available-for-sale Securities, Amortized Cost Basis of $1.65 million as of 2015-12-31, per its 10-K filed 2017-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2017-03-15
- 2015-12-31: Available-for-sale Securities, Amortized Cost Basis $1.65M.
- 2015-09-30: Available-for-sale Securities, Amortized Cost Basis $2.90M.
- 2015-03-31: Available-for-sale Securities, Amortized Cost Basis $5.61M.
- 2014-12-31: Available-for-sale Securities, Amortized Cost Basis $7.41M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2015-12-31 | $1.65M 10-K · filed 2017-03-15 |
| 2015-09-30 | $2.90M 10-Q · filed 2015-11-16 |
| 2015-03-31 | $5.61M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $7.41M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |